Gabriele MARCOLONGO

City:

Milan

Country:

Italy

Published Applications:

Last publication date:

2023-11-30

Top Assignees for applications by Gabriele MARCOLONGO

The entities that hold a legal rights for patent applications filed by inventor MARCOLONGO Gabriele:

EPITECH GROUP S.P.A. 5 Milan, Italy
Epitech Group S.P.A. 3 Milano, Italy
Epitech Group S.r.l. 3 Milan, Italy
EPITECH GROUP S.R.L. 2 Milano, Italy
Innovet Italia S.R.L. 1 Milano, Italy
Innovet Italia S.R.L. 1 Milan, Italy

Recent patent applications by MARCOLONGO Gabriele

Gabriele MARCOLONGO from Milan, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-30

US20230381121A1

Human necessities

N-PALMITOYLETHANOLAMIDE AND MELATONIN FOR USE IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROBEHAVIORAL DISORDERS SIMILARLY ACCOMPANIED BY RESTLESSNESS, IRRITABILITY, SLEEP DISORDERS, AND POTENTIALLY STEREOTYPIES

#2 | 2023-04-06

US20230104124A1

Human necessities

N-PALMITOYLETHANOLAMIDE AND DOCOSAHEXAENOIC ACID FOR USE IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER DEPRESSIVE SYNDROMES

#3 | 2022-12-01

US20220378725A1

Human necessities

Composition of acylethanolamides from olive oil fatty acids

#4 | 2022-09-29

US20220304956A1

Human necessities

METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHANOLAMIDE

#5 | 2021-10-07

US20210308160A1

Human necessities

N-palmitoyl-D-glucosamine in a micronized form

#6 | 2021-03-04

US20210060047A1

Human necessities

Composition of N-palmitoyl-ethanolamide and Rutin in co-micronized form

#7 | 2019-07-25

US20190224145A1

Human necessities

Use of a combination of Adelmidrol and hyaluronic acid in the treatment of pain caused by osteoarthritis and epithelial dysfunctions

#8 | 2015-06-11

US20150157733A1

Human necessities

Polyethylene glycol derivatives of palmitoylethanolamide and analogous acylethanolamides

#9 | 2015-02-26

US20150057269A1

Chemistry; metallurgy

Compositions and methods for the modulation of specific amidases for N-acylethanolamines for use in the therapy of inflammatory diseases

#10 | 2015-01-08

US20150011617A1

Human necessities

Combined use of amides of mono- and dicarboxylic acids and silymarin in the treatment of renal diseases

InventorID:

5013899 ⎘